Health Check: And the EOFY biotech winner is … gasp … a pot stock
Dr Boreham’s Crucible: ‘Better not louder’, Audeara is tuned in to the global audiology market
Top 10 at 11: Info tech lifts ASX as small caps revamp capital and asset structures
We’re getting richer quicker, and by the trillions
DY6 sampling reveals extensive rutile zone with large nuggets
Antipa expands Minyari with new gold-copper discovery
Trajan’s tech is enabling research into next-gen aviation fuels
Many Peaks Minerals retains option to acquire Baga gold project
Rise and Shine: Everything you need to know before the ASX opens
Closing Bell: Healthcare sector gives ASX a booster to rise 0.33pc
Contributors
Our Resident Experts
Mining
Kristie Batten: Koonenberry Gold sees shades of De Grey success story at Sunnyside
StockTake: Uvre to dot the i’s and cross the t’s on New Zealand gold pickup
Lithium customers are still jostling for offtake, suggesting long term outlook is strong
Barry FitzGerald: Why Wildcat may be the BESS buy as lithium demand goes through the roof
Gold Digger: Platinum spins new 11-year record
Tech
AI ‘havoc’ warning: expert calls for radical solution
Xero aims to crack US market by buying accounting platform Melio Payments
BlackRock calls defence tech the next theme to watch as NATO shifts into rearm mode
Ten Pound Poms: Australia looks to UK to fill 200,000 tech roles
Is it time to move on from ‘old gold’ defensive strategies?
Featured in Tech
Health & Biotech
Dr Boreham’s Crucible: ‘Better not louder’, Audeara is tuned in to the global audiology market
Health Check: Tetratherix breaks biotech IPO drought with 13pc gain on debut
Health Check: Paradigm makes scenic acquisitive detour, but it’s no strategic shift
Health Check: UBS turns ultra-bullish on Aussie healthcare leaders
Biocurious: CSL’s R&D chief says drug development is like falling in love
Featured in Health & Biotech
Experts
Criterion: Virgin’s trumphant float means more IPOs should be cleared for take-off
Stock Tips: Expert eyes are on WiseTech and Santos this week
The ‘outlandish’ property schemes hurting homebuyers
Is it time to move on from ‘old gold’ defensive strategies?
The four traits of successful investors
Broker Upgrades: WA gold developer becomes Canaccord’s latest ‘spec buy’
The 9 lowest home loan rates you can get right now
